Literature DB >> 1376756

Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis.

G H Bothamley1, J S Beck, R C Potts, J M Grange, T Kardjito, J Ivanyi.   

Abstract

Specific antibody levels and delayed-type hypersensitivity skin responses to antigens of Mycobacterium tuberculosis in 39 hospital staff who were heavily exposed to tuberculosis (TB) were compared with those in 36 factory employees from Indonesia. Antibody levels to the TB68 epitope of the 14-kDa antigen were significantly greater, while titers to the TB23 (19-kDa) and TB72 (38-kDa) epitopes and lipoarabinomannan (LAM) were lower in exposed than in nonexposed subjects (all P less than .02). The intensity of tuberculin responses correlated positively with anti-LAM and negatively with anti-19-kDa antibody levels. Possible reasons for the selective humoral response of chronically exposed healthy subjects to the 14-kDa antigen, but not to other antigens immunogenic in patients with tuberculosis, are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376756     DOI: 10.1093/infdis/166.1.182

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Mycobacterium bovis BCG scar status and HLA class II alleles influence purified protein derivative-specific T-cell receptor V beta expression in pulmonary tuberculosis patients from southern India.

Authors:  S Shanmugalakshmi; V Dheenadhayalan; P Muthuveeralakshmi; G Arivarignan; R M Pitchappan
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung.

Authors:  Lanbo Shi; Robert North; Maria Laura Gennaro
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

4.  The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.

Authors:  Saet-Byel Jung; Chul-Su Yang; Ji-Sook Lee; A-Rum Shin; Sung-Soo Jung; Ji Woong Son; Clifford V Harding; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Chang-Hwa Song; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients.

Authors:  Shajo Kunnath-Velayudhan; Amy L Davidow; Hui-Yun Wang; Douglas M Molina; Vu T Huynh; Hugh Salamon; Richard Pine; Gerd Michel; Mark D Perkins; Liang Xiaowu; Philip L Felgner; JoAnne L Flynn; Antonino Catanzaro; Maria L Gennaro
Journal:  J Infect Dis       Date:  2012-06-25       Impact factor: 5.226

6.  Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv.

Authors:  Hiwa Målen; Sharad Pathak; Tina Søfteland; Gustavo A de Souza; Harald G Wiker
Journal:  BMC Microbiol       Date:  2010-04-29       Impact factor: 3.605

7.  Human T cell responses to peptide epitopes of the 16-kD antigen in tuberculosis.

Authors:  G Friscia; H M Vordermeier; G Pasvol; D P Harris; C Moreno; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

8.  Epitope-specific antibody levels demonstrate recognition of new epitopes and changes in titer but not affinity during treatment of tuberculosis.

Authors:  Graham H Bothamley
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 9.  Diagnosis of tuberculosis: available technologies, limitations, and possibilities.

Authors:  Sanjay K Garg; R P Tiwari; Dileep Tiwari; Rupinder Singh; Dolly Malhotra; V K Ramnani; G B K S Prasad; Ramesh Chandra; M Fraziano; V Colizzi; Prakash S Bisen
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

Review 10.  Malaria vaccines.

Authors:  R Amador; M E Patarroyo
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.